Corcept Therapeutics (CORT) Deferred Taxes (2017 - 2026)
Corcept Therapeutics (CORT) posted Deferred Taxes of $2.9 million for Q2 2026, up 121.98% sequentially from -$13.1 million in Q1 2026, and up 116.22% YoY from $1.3 million in Q2 2025.
Corcept Therapeutics (CORT) Deferred Taxes (2017 - 2026) Analysis & Trends
Corcept Therapeutics has reported Deferred Taxes for 10 years, with the latest figure at $2.9 million in Q2 2026.
- Quarterly Deferred Taxes rose 116.22% year-over-year to $2.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$16.3 million (up 67.75% YoY) and the FY2025 annual result came in at -$37.5 million, up 6.6% from the prior year.
- Deferred Taxes rose to $2.9 million in Q2 2026 per CORT's latest filing, from -$13.1 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $9.1 million in Q3 2025 and troughed at -$17.8 million in Q2 2025.
- A 5-year average of -$8.4 million and a median of -$9.4 million in 2022 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2022 and 2025: Deferred Taxes tumbled 678.8% in 2022, then soared 159.93% in 2025.
- Over 5 years, Deferred Taxes stood at -$4.5 million in 2022, then increased by 17.8% to -$3.7 million in 2023, then slipped by 5.07% to -$3.9 million in 2024, then tumbled by 293.52% to -$15.2 million in 2025, then surged by 118.98% to $2.9 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $2.9 million, -$13.1 million, and -$15.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Mn |
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -15.18 Mn |
| Sep 30, 2025 | 9.11 Mn |
| Jun 30, 2025 | -17.76 Mn |
| Mar 31, 2025 | -13.71 Mn |
| Dec 31, 2024 | -3.86 Mn |
| Sep 30, 2024 | -15.21 Mn |
| Jun 30, 2024 | -13.96 Mn |
| Mar 31, 2024 | -7.16 Mn |
| Dec 31, 2023 | -3.67 Mn |
| Sep 30, 2023 | -8.86 Mn |
| Jun 30, 2023 | -10.24 Mn |
| Mar 31, 2023 | -6.73 Mn |
| Dec 31, 2022 | -4.47 Mn |
| Sep 30, 2022 | -8.87 Mn |
| Jun 30, 2022 | -10.63 Mn |
| Mar 31, 2022 | -9.94 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 1.53 Mn |